Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Quality and Regulatory Requirements for the Manufacture of Master Cell Banks of Clinical Grade iPSCs: The EU and USA Perspectives

17 Jan 2025

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomedical Ethics and Regulation
Share to Health Systems, Economic Evaluations, Quality of Life

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 39821060
DOI: 10.1007/s12015-024-10838-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Quality and Regulatory Requirements for the Manufacture of Master Cell Banks of Clinical Grade iPSCs: The EU and USA PerspectivesPMID 39821060Read ↗

cGMP-Manufactured Human Induced Pluripotent Stem Cells Are Available for Pre-clinical and Clinical ApplicationsSemantic proximity Read ↗

Quality Control Guidelines for Clinical-Grade Human Induced Pluripotent Stem Cell LinesSemantic proximity Read ↗

Bioprocessing considerations for generation of iPSCs intended for clinical application: perspectives from the ISCT Emerging Regenerative Medicine Technology working groupSemantic proximity Read ↗

Consensus Guidance for Banking and Supply of Human Embryonic Stem Cell Lines for Research PurposesSemantic proximity Read ↗

Human-Induced Pluripotent Stem Cells Manufactured Using a Current Good Manufacturing Practice-Compliant Process Differentiate Into Clinically Relevant Cells From Three Germ LayersSemantic proximity Read ↗

The Procurement of Cells for the Derivation of Human Embryonic Stem Cell Lines for Therapeutic Use: Recommendations for Good PracticeSemantic proximity Read ↗

Harmonizing standards for producing clinical-grade therapies from pluripotent stem cellsSemantic proximity Read ↗

Lessons learnt, and still to learn, in first in human stem cell trialsSemantic proximity Read ↗

Development and implementation of large-scale quality control for the European bank for induced Pluripotent Stem CellsSemantic proximity Read ↗

Good Manufacturing Practice–compliant human induced pluripotent stem cells: from bench to putative clinical productsSemantic proximity Read ↗

Development and production of good manufacturing practice grade human embryonic stem cell lines as source material for clinical applicationSemantic proximity Read ↗

Detailed Characterization of Human Induced Pluripotent Stem Cells Manufactured for Therapeutic Applications.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.